Atu027: Completed Phase Ib/IIa enrollment

Silence said it completed enrollment of 24 patients with locally advanced or metastatic pancreatic adenocarcinoma in the Phase

Read the full 183 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE